Regis (NYSE: RGS ) reported earnings on Jan. 31. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q2), Regis met expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue dropped and GAAP loss per share dropped.
Gross margins shrank, operating margins dropped, net margins expanded.
Revenue details
Regis reported revenue of $506.2 million. The six analysts polled by S&P Capital IQ expected to see a top line of $504.2 million on the same basis. GAAP reported sales were 10% lower than the prior-year quarter's $563.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at $0.03. The seven earnings estimates compiled by S&P Capital IQ anticipated $0.14 per share. GAAP EPS were -$0.22 for Q2 compared to -$1.01 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Margin details
For the quarter, gross margin was 33.0%, 410 basis points worse than the prior-year quarter. Operating margin was 1.7%, 240 basis points worse than the prior-year quarter. Net margin was -2.4%, 780 basis points better than the prior-year quarter.
Looking ahead
Next quarter's average estimate for revenue is $525.7 million. On the bottom line, the average EPS estimate is $0.22.
Next year's average estimate for revenue is $2.06 billion. The average EPS estimate is $0.67.
Investor sentiment
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Regis is hold, with an average price target of $16.93.
Looking for alternatives to Regis? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Regis to My Watchlist.
No comments:
Post a Comment